Prot# AVF3261s: An Open Label Multicenter Phase II Study of Bevacizumab for the Treatment of Angiosarcoma (NU Prot# NU 04S1)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/27/0512/31/14

Funding

  • Genentech, Inc. (AVF3261s/NU 04S1)